Month: October 2015

  • Cancer Institute Spins-Off Company, Gains Licensing Deal

    14 October 2015. Ontario Institute for Cancer Research is spinning off a new enterprise to discover therapies for blood-related cancers, and will partner with Janssen Biotech Inc. to take those therapies to market. The licensing deal between Novera Therapeutics Inc., the OICR spin-off company in Toronto, and Janssen Biotech, a division of Johnson & Johnson,…

  • Universal Wireless Charging Device Designed

    14 October 2015. Engineering researchers designed a prototype device that can simultaneously charge mobile phones compatible with leading wireless charging specifications. Dukju Ahn and Patrick Mercier at University of California in San Diego describe their device in a recent issue of the journal IEEE Transactions on Power Electronics (paid subscription required). Wireless charging of mobile devices…

  • Institute, GlaxoSmithKline ID Tuberculosis Candidates

    13 October 2015. A biomedical research institute partnered with a lab backed by pharmaceutical company GlaxoSmithKline to identify candidates for drugs that act on bacteria causing tuberculosis. The team from Center for Infectious Disease Research in Seattle and Tres Cantos Open Lab Foundation, a lab in Spain sponsored by GlaxoSmithKline, published its findings in a…

  • Spin-Off to Provide Lower-Cost Molecular Imaging Technology

    13 October 2015. A new enterprise based on research at Harvard University is offering a technology that allows ordinary microscopes to display high resolution images of single molecules. The company, Ultivue Inc., is founded by and licensing technologies from the lab of Peng Yin at Harvard’s Wyss Institute for Biologically Inspired Engineering. Yin and colleagues…

  • Study Shows Blood Test Finds Early Pancreatic Cancer

    12 October 2015. An evaluation of a blood test to find early stages of pancreatic cancer showed the test successfully identified early-stage cancer in the vast majority of study participants with the disease. The findings published by a team from diagnostics company VolitionRx in Belgium and Lund University in Sweden appeared last week in the…

  • Patent Awarded for Slower Digested Wheat

    12 October 2015. A type of wheat digested more slowly than regular wheat, and thus releases glucose more slowly into the blood stream, received a patent from the U.S. Patent and Trademark Office. Patent number 9,150,839, titled “Wheat with increased resistant starch levels ,” was awarded on 2 October to four inventors and assigned to…

  • Chip Device in Development to Simulate Human Gut

    9 October 2015. A team of medical researchers and engineers in North Carolina is developing a miniaturized device derived from human stem cells to better simulate the workings of a human gut. The five-year project is funded by $5.3 million grant from National Institute of Diabetes and Digestive and Kidney Diseases, part of National Institutes…

  • Harvard Spin-Off Commercializing Sepsis Treatment

    9 October 2015. A new enterprise spun-off from Harvard University is developing a device for treating sepsis, a life-threatening infection often contracted in hospitals. The company, Opsonix Inc. in Boston, also raised $8 million in its first round of venture funding. Opsonix is licensing a technology for treating sepsis developed in Harvard’s Wyss Institute for…

  • Eli Lilly Expanding NYC Labs for Cancer Therapies

    9 October 2015. The pharmaceutical company Eli Lilly and Company is expanding its research labs in New York City to boost discoveries of cancer therapies that harness the immune system. Lilly expects to hire 50 more research and support staff as part of the expansion. The company’s new facility will inhabit 30,000 square feet in…

  • On Assignment

    8 October 2015. We’re covering a story in New York today, so we will not be posting any items. We’ll resume our regular posting tomorrow. *     *     *